EXELON

Main information

  • Trade name:
  • EXELON 60/60 CAP
  • Dosage:
  • 1.5/3;MG
  • Pharmaceutical form:
  • CAP
  • Composition:
  • 60/60
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EXELON 60/60 CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

12-3-2018

RIVASTIGMINE TARTRATE Capsule [McKesson Corporation]

RIVASTIGMINE TARTRATE Capsule [McKesson Corporation]

Updated Date: Mar 12, 2018 EST

US - DailyMed

18-1-2018

Rivastigmine

Rivastigmine

Rivastigmine is a reversible cholinesterase inhibitor used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. Rivastigmine is available under the following different brand names: Exelon, and Exelon Patch.

US - RxList

2-1-2018

EXELON (Rivastigmine Tartrate) Capsule [Novartis Pharmaceuticals Corporation]

EXELON (Rivastigmine Tartrate) Capsule [Novartis Pharmaceuticals Corporation]

Updated Date: Jan 2, 2018 EST

US - DailyMed

29-12-2017

RIVASTIGMINE TARTRATE Capsule [Golden State Medical Supply, Inc.]

RIVASTIGMINE TARTRATE Capsule [Golden State Medical Supply, Inc.]

Updated Date: Dec 29, 2017 EST

US - DailyMed

28-12-2017

RIVASTIGMINE TRANSDERMAL SYSTEM Patch, Extended Release [Alvogen Inc.]

RIVASTIGMINE TRANSDERMAL SYSTEM Patch, Extended Release [Alvogen Inc.]

Updated Date: Dec 28, 2017 EST

US - DailyMed

20-11-2017

RIVASTIGMINE TARTRATE Capsule [Major Pharmaceuticals]

RIVASTIGMINE TARTRATE Capsule [Major Pharmaceuticals]

Updated Date: Nov 20, 2017 EST

US - DailyMed

24-10-2017

RIVASTIGMINE TARTRATE Capsule [Ajanta Pharma Limited]

RIVASTIGMINE TARTRATE Capsule [Ajanta Pharma Limited]

Updated Date: Oct 24, 2017 EST

US - DailyMed

11-10-2017

RIVASTIGMINE TARTRATE Capsule [Breckenridge Pharmaceutical, Inc]

RIVASTIGMINE TARTRATE Capsule [Breckenridge Pharmaceutical, Inc]

Updated Date: Oct 11, 2017 EST

US - DailyMed

8-9-2017

RIVASTIGMINE TARTRATE Capsule [Nivagen Pharmaceuticals, Inc.]

RIVASTIGMINE TARTRATE Capsule [Nivagen Pharmaceuticals, Inc.]

Updated Date: Sep 8, 2017 EST

US - DailyMed

15-8-2017

RIVASTIGMINE TARTRATE Capsule [Apotex Corp.]

RIVASTIGMINE TARTRATE Capsule [Apotex Corp.]

Updated Date: Aug 15, 2017 EST

US - DailyMed

28-7-2017

Rivastigmine 1 A Pharma (1 A Pharma GmbH)

Rivastigmine 1 A Pharma (1 A Pharma GmbH)

Rivastigmine 1 A Pharma (Active substance: Rivastigmine) - Centralised - Yearly update - Commission Decision (2017)5353 of Fri, 28 Jul 2017

Europe -DG Health and Food Safety

19-7-2017

Rivastigmine Sandoz (Sandoz GmbH)

Rivastigmine Sandoz (Sandoz GmbH)

Rivastigmine Sandoz (Active substance: Rivastigmine) - Centralised - Yearly update - Commission Decision (2017)5167 of Wed, 19 Jul 2017

Europe -DG Health and Food Safety

26-5-2017

RIVASTIGMINE TARTRATE Capsule [Cadila Pharmaceuticals Limited]

RIVASTIGMINE TARTRATE Capsule [Cadila Pharmaceuticals Limited]

Updated Date: May 26, 2017 EST

US - DailyMed